Search

Andrew J. Wang

Examiner (ID: 5764)

Most Active Art Unit
1635
Art Unit(s)
1621, 1639, 1635, 1809, 2628
Total Applications
378
Issued Applications
235
Pending Applications
93
Abandoned Applications
50

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3883428 [patent_doc_number] => 05833977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Method of improving the quality of plant seeds using lactic acid producing micro-organisms' [patent_app_type] => 1 [patent_app_number] => 8/765931 [patent_app_country] => US [patent_app_date] => 1997-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5458 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833977.pdf [firstpage_image] =>[orig_patent_app_number] => 765931 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/765931
Method of improving the quality of plant seeds using lactic acid producing micro-organisms Jan 13, 1997 Issued
Array ( [id] => 3785485 [patent_doc_number] => 05840575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'DNA ladders' [patent_app_type] => 1 [patent_app_number] => 8/781866 [patent_app_country] => US [patent_app_date] => 1997-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 2993 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840575.pdf [firstpage_image] =>[orig_patent_app_number] => 781866 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/781866
DNA ladders Jan 9, 1997 Issued
Array ( [id] => 1531736 [patent_doc_number] => 06410224 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Ribozyme treatment of diseases or conditions related to levels of NF-B' [patent_app_type] => B1 [patent_app_number] => 08/777916 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20486 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410224.pdf [firstpage_image] =>[orig_patent_app_number] => 08777916 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/777916
Ribozyme treatment of diseases or conditions related to levels of NF-B Dec 22, 1996 Issued
Array ( [id] => 4180262 [patent_doc_number] => 06150092 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Antisense nucleic acid compound targeted to VEGF' [patent_app_type] => 1 [patent_app_number] => 8/765340 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150092.pdf [firstpage_image] =>[orig_patent_app_number] => 765340 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/765340
Antisense nucleic acid compound targeted to VEGF Dec 22, 1996 Issued
Array ( [id] => 3994829 [patent_doc_number] => 05922539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods for use of mismatch repair systems for the detection and removal of mutant sequences that arise during enzymatic amplification' [patent_app_type] => 1 [patent_app_number] => 8/767258 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 9713 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922539.pdf [firstpage_image] =>[orig_patent_app_number] => 767258 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/767258
Methods for use of mismatch repair systems for the detection and removal of mutant sequences that arise during enzymatic amplification Dec 12, 1996 Issued
Array ( [id] => 3882416 [patent_doc_number] => 05776685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Protein kinase C assay' [patent_app_type] => 1 [patent_app_number] => 8/752047 [patent_app_country] => US [patent_app_date] => 1996-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10472 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776685.pdf [firstpage_image] =>[orig_patent_app_number] => 752047 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/752047
Protein kinase C assay Nov 18, 1996 Issued
Array ( [id] => 1506833 [patent_doc_number] => 06440660 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Oligonucleotide mediated reversal of drug resistance' [patent_app_type] => B1 [patent_app_number] => 08/745485 [patent_app_country] => US [patent_app_date] => 1996-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11860 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440660.pdf [firstpage_image] =>[orig_patent_app_number] => 08745485 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/745485
Oligonucleotide mediated reversal of drug resistance Nov 11, 1996 Issued
08/744211 REAGENTS AND METHODS USEFUL FOR DETECTING LUNG DISEASE Nov 4, 1996 Abandoned
Array ( [id] => 3780646 [patent_doc_number] => 05821062 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Oligonucleotide for use in checking presence or absence of mutation in human-derived cytochrome P450IIC18 gene' [patent_app_type] => 1 [patent_app_number] => 8/716459 [patent_app_country] => US [patent_app_date] => 1996-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7791 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821062.pdf [firstpage_image] =>[orig_patent_app_number] => 716459 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/716459
Oligonucleotide for use in checking presence or absence of mutation in human-derived cytochrome P450IIC18 gene Nov 4, 1996 Issued
Array ( [id] => 4179736 [patent_doc_number] => 06020144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same' [patent_app_type] => 1 [patent_app_number] => 8/735507 [patent_app_country] => US [patent_app_date] => 1996-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19894 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020144.pdf [firstpage_image] =>[orig_patent_app_number] => 735507 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/735507
Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same Oct 22, 1996 Issued
08/702724 INHIBITION OF CELL PROLIFERATION BY E2F-1 ANTISENSE OLIGONUCLEOTIDES Oct 16, 1996 Abandoned
Array ( [id] => 3995481 [patent_doc_number] => 05922583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods for production of recombinant plasmids' [patent_app_type] => 1 [patent_app_number] => 8/732612 [patent_app_country] => US [patent_app_date] => 1996-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10607 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922583.pdf [firstpage_image] =>[orig_patent_app_number] => 732612 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/732612
Methods for production of recombinant plasmids Oct 15, 1996 Issued
Array ( [id] => 4049804 [patent_doc_number] => 05932417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/729955 [patent_app_country] => US [patent_app_date] => 1996-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17527 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932417.pdf [firstpage_image] =>[orig_patent_app_number] => 729955 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/729955
Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells Oct 14, 1996 Issued
Array ( [id] => 4188717 [patent_doc_number] => 06093806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'DNA encoding proteins of Kaposi\'s sarcoma associated herpesvirus' [patent_app_type] => 1 [patent_app_number] => 8/728603 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14718 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093806.pdf [firstpage_image] =>[orig_patent_app_number] => 728603 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/728603
DNA encoding proteins of Kaposi's sarcoma associated herpesvirus Oct 9, 1996 Issued
08/731199 ANTISENSE OLIGONUCLEOTIDE MODULATION OF MDR P-GLYCOPROTEIN GENE EXPRESSION Oct 3, 1996 Abandoned
Array ( [id] => 3768744 [patent_doc_number] => 05756310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'CDNA encoding a human phospholemman-like protein (HPLP)' [patent_app_type] => 1 [patent_app_number] => 8/725531 [patent_app_country] => US [patent_app_date] => 1996-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16401 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756310.pdf [firstpage_image] =>[orig_patent_app_number] => 725531 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/725531
CDNA encoding a human phospholemman-like protein (HPLP) Oct 2, 1996 Issued
Array ( [id] => 4199184 [patent_doc_number] => 06013660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Externally targeted prophylactic and chemotherapeutic method and agents' [patent_app_type] => 1 [patent_app_number] => 8/724814 [patent_app_country] => US [patent_app_date] => 1996-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 15894 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013660.pdf [firstpage_image] =>[orig_patent_app_number] => 724814 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/724814
Externally targeted prophylactic and chemotherapeutic method and agents Oct 1, 1996 Issued
08/722116 METHODS OF TREATING EUKARYOTIC CELLS Sep 17, 1996 Abandoned
Array ( [id] => 4038001 [patent_doc_number] => 05856435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Nucleic acid-containing composition, its preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/687551 [patent_app_country] => US [patent_app_date] => 1996-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5823 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856435.pdf [firstpage_image] =>[orig_patent_app_number] => 687551 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/687551
Nucleic acid-containing composition, its preparation and use Aug 25, 1996 Issued
Array ( [id] => 1484671 [patent_doc_number] => 06365345 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role' [patent_app_type] => B1 [patent_app_number] => 08/666341 [patent_app_country] => US [patent_app_date] => 1996-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2572 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365345.pdf [firstpage_image] =>[orig_patent_app_number] => 08666341 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/666341
Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role Aug 14, 1996 Issued
Menu